Hepatic Steatosis Index Predicts Gestational Hypertension & Preeclampsia - News Directory 3

Hepatic Steatosis Index Predicts Gestational Hypertension & Preeclampsia

February 26, 2025 Catherine Williams Health
News Context
At a glance
  • Researchers have discovered a significant association between the Hepatic Steatosis Index (HSI) and the risk of gestational hypertension (GH) and preeclampsia (PE).
  • Eclampsia and preeclampsia are severe conditions that can lead to organ dysfunction, including liver damage, cardiac and renal insufficiency.
  • Investigators examined data from participants in the China Birth Cohort Study who delivered live-born singletons at Beijing Obstetrics and Gynecology Hospital, Capital Medical University, from February 2018 to...
Original source: contemporaryobgyn.net

Hepatic Steatosis Index: A Potential Predictor for Gestational Hypertension and Preeclampsia in Pregnant Women

Table of Contents

There may be a link of Hepatic Steatosis Index (HSI) with gestational hypertension (GH) and preeclampsia (PE) risk, according to a recent study.


Researchers have discovered a significant association between the Hepatic Steatosis Index (HSI) and the risk of gestational hypertension (GH) and preeclampsia (PE). Published in the International Journal of Medical Sciences, the study sheds light on how NAFLD, a leading cause of liver disease, can predict these pregnancy complications. This finding has profound implications for maternal health, particularly in the United States, where obesity and related conditions are prevalent.

Eclampsia and preeclampsia are severe conditions that can lead to organ dysfunction, including liver damage, cardiac and renal insufficiency. Risk factors for these conditions include hypertension, diabetes, obesity, and advanced maternal age. According to the study, “An HSI value of 36.0 detects NAFLD with a specificity of 93.1% (95% CI, 92.0-94.0) and a positive likelihood ratio of 6.505 (95% CI, 5.628-7.519), indicating its reliability as a screening tool.

Investigators examined data from participants in the China Birth Cohort Study who delivered live-born singletons at Beijing Obstetrics and Gynecology Hospital, Capital Medical University, from February 2018 to December 2022. The study excluded individuals with incomplete liver enzyme tests, pre-existing hypertension, severe renal diseases, and missing covariate data. The researchers used a standardized questionnaire to collect baseline data, which included ethnicity, maternal age, employment status, height and weight, educational level, and other pertinent medical history.

The study categorized participants into groups based on their health statuses: normal, GH, or PE. Among the 39,114 participants, 4.3% were diagnosed with GH, and 4.1% with PE. The study found that serum markers ALT, AST, and GGT all exhibited significant differences between the groups, indicating their relevance as potential biomarkers.

“Higher HIS scores vs. the first quartile were linked to increased GH risk, with odds ratios (ORs) of 1.354, 1.858, and 3.808 for the second, third, and fourth quartiles, respectively. Additionally, PE risk also significantly increased from the highest quartiles of GGT and HSI, with ORs of 1.978 and 3.602, respectively.

Implications for Maternal Health in the United States

These findings are particularly relevant in the U.S., where maternal health has been a growing concern. Obesity and related metabolic disorders, which are closely linked to NAFLD, affect a significant portion of the population. Pregnant women with these conditions are at a higher risk for complications such as GH and PE.

The study underscores the need for early screening and intervention. For women under 35, the predictive value of HSI was even stronger, highlighting the importance of regular check-ups and monitoring. Healthcare providers can use HSI as a tool to identify high-risk patients and implement preventive measures.

The Role of Lifestyle and Diet

  • The association between NAFLD and pregnancy complications underscores the importance of a healthy lifestyle and diet, particularly for women of childbearing age.
  • In the U.S., conditions like diabetes and obesity are prevalent and closely linked to NAFLD. By improving diet and lifestyle, women can reduce their risk of complications.

Challenges and Future Directions

The study highlights several challenges and areas for future research. Given the prevalence of NAFLD in the U.S., more extensive studies are needed to validate these findings in a broader population. Additionally, healthcare providers must be trained to utilize HSI effectively as a predictive tool.

The National Institutes of Health (NIH) has been investing in research to improve maternal health outcomes. This study aligns with initiatives aimed at reducing maternal mortality and morbidity. By integrating HSI into routine prenatal care, healthcare professionals can better manage and prevent complications.

Conclusion

This groundbreaking study offers a new perspective on predicting gestational hypertension and preeclampsia risk using the Hepatic Steatosis Index. Its implications are far-reaching, particularly in the U.S., where maternal health is a public health priority. With further research and improved healthcare practices, the approach could significantly enhance the quality of prenatal care and reduce adverse outcomes for both mothers and their babies.

“These findings illustrate the importance of NAFLD as a potential risk factor for GH and PE and highlight the need for in-depth research into perinatal primary prevention measures for women with NAFLD,”

— Investigators, International Journal of Medical Sciences

Further Reading

  • Zhang L, Gao S, Luan Y. Predictivity of hepatic steatosis index for gestational hypertension and preeclampsia: a prospective cohort study. Int J Med Sci. …..
  • Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy hypertension. 2018;13:291-310.

Q&A on Hepatic Steatosis Index and Its Role in Predicting Gestational Hypertension and Preeclampsia

What is the Hepatic Steatosis Index (HSI) and How is it Used in Pregnancy Complications?

  • Definition: The Hepatic Steatosis Index (HSI) is a noninvasive tool used to predict non-alcoholic fatty liver disease (NAFLD), which is increasingly recognized as a potential risk factor for gestational hypertension (GH) and preeclampsia (PE) during pregnancy.
  • Significance: A recent study published in the international Journal of Medical Sciences demonstrated a notable link between elevated HSI and the increased risk of GH and PE in pregnant women. This suggests that HSI can serve as a reliable screening tool for identifying high-risk individuals early in pregnancy. [[3]][1]

How Reliable is HSI as a Screening Tool?

  • Accuracy: HSI has been shown to detect NAFLD with a specificity of 93.1% and a positive likelihood ratio of 6.505, making it a reliable predictor of related pregnancy complications.
  • Statistical Findings: Research indicates that women with higher HSI scores have a notably increased risk of developing GH and PE, with odds ratios (ORs) demonstrating a progressive increase across different HSI quartiles. [[3]][2]

Why is HSI Especially Relevant for Pregnant Women in the U.S.?

  • Prevalence of NAFLD: Given the high prevalence of obesity and metabolic disorders like NAFLD in the United States, HSI offers a crucial screening method for maternal healthcare professionals aiming to mitigate the risk of GH and PE.
  • Health Implications: Early identification and management of at-risk pregnancies can prevent severe complications, including organ damage, enhancing both maternal and infant health outcomes.

What are the Implications of HSI Findings for Maternal Health?

  • Importance of Early Detection: The study underscores the necessity for regular prenatal check-ups and screenings for women, particularly those with metabolic disorders, to identify and manage risks early.
  • Lifestyle Impact: Improving diet and adhering to a healthy lifestyle may significantly reduce the risks associated with NAFLD and related pregnancy complications. [[3]][4]

What Challenges and Future Directions are Highlighted by These Findings?

  • Need for Further Research: Despite promising results, more extensive studies are required to validate HSI’s predictive capacity in diverse populations and to establish it as a standard part of prenatal care.
  • Training and Integration: Healthcare providers must be equipped to utilize HSI effectively within routine screenings to enhance maternal and neonatal health outcomes.

Conclusion

The research into HSI as a predictor for gestational hypertension and preeclampsia offers profound implications for enhancing maternal care. By integrating HSI screening into prenatal practices, healthcare providers can significantly mitigate adverse maternal outcomes, particularly in populations at higher risk for obesity and metabolic disorders.

For further details on this topic, readers may refer to articles such as “Predictivity of Hepatic Steatosis Index for Gestational Hypertension and Preeclampsia: A Prospective Cohort Study” by Zhang et al., published in the International Journal of Medical Sciences.

References:

[1]: Elevated Hepatic Steatosis Index is Associated with the Growth of …

[2]: comparison of hepatic steatosis index as noninvasive diagnostic tool

[3]: Association Between the Hepatic Steatosis Index and Risk of Incident …

, , , , ,